D-0198-2020 Class II Terminated

Recalled by First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy — Mesa, AZ

FDA drug recall D-0198-2020 was initiated by First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy on August 12, 2019 and is designated Class II. Reason for recall: Lack of Assurance of Sterility The recall status is terminated (terminated April 13, 2023). Affected quantity: 2 x 30 mL vials.

Recall Details

Product Type
Drugs
Report Date
November 13, 2019
Initiation Date
August 12, 2019
Termination Date
April 13, 2023
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
2 x 30 mL vials

Product Description

S-AMITRIPTYLINE 10MG/ML MDV INJ SOLN, 30ML, glass vial, Rx Only, Red Mountain Compounding RX

Reason for Recall

Lack of Assurance of Sterility

Distribution Pattern

Nationwide in the USA

Code Information

Lot #: S06272019DT@08, BUD: 9/27/2019